Drawing for ADRIEN GAGNON

USPTO serial 88976227

ADRIEN GAGNON

Reviewed by CopyMark Law Group

Reg. 5940312Status 710
Filing date
Status date
Registration date
Dec 17, 2019
Examiner
PARK, JENNY K
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ADRIEN GAGNON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph V. Myers III

JOSEPH V. MYERS III SEYFARTH SHAW LLP1075 PEACHTREE STREET, SUITE 2500ATLANTA, GA 30309UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Natural products for human use, namely, a formula composed of saw palmetto, pygeum, stinging nettle, white deadnettle, common heather and bearberry, all in the form of capsules for relieving benign prostate hyperplasia symptoms; collagen, in the form of tablets for relieving joint pain and symptoms related to arthritis and osteoarthritis and for contributing to the formation of healthy cartilage; Natural products for human use, namely, capsules containing plant extracts to assist in weight loss; Natural products for human use, namely, plant and vitamin extracts in the form of ampoules and capsules for soothing respiratory symptoms due to a cold, flu, bronchitis and for increasing the bio-availability of Vitamin C by decreasing its elimination and oxidation; Natural products for human use, namely, plant extracts in the form of infusions, with purifying, eliminative, diuretic and laxative actions; Natural products for human use, namely, a supplement formula made of vitamins, plants and adaptogenic roots in the form of energizing ampoules, to increase resistance to stress and decrease the feeling of fatigue; Natural products for human use, namely, a supplement formula made of adaptogenic plants and roots in the form of energizing ampoules, to increase resistance to stress and decrease the feeling of fatigue, to decrease hyperglycemia and stimulate weakened immune systems and cognitive functions; Natural products for human use, namely, plant and root extracts in the form of capsules and ampoules to assist in slowing the advancement of benign prostate hypertrophy, controlling sleep disorders; a fatty acid and vitamin formula in the form of capsules for physical endurance, cholesterol level management and for the maintenance of good health; Natural products for human use, namely, plant extracts and antioxidant roots and fish oils in the form of capsules, gelcaps, liquids, to improve the cognitive functions of patients suffering from Alzheimer's or minor memory disorders, to contribute to the development and proper functioning of the brain; Natural products for human use, namely, type II collagen containing chondroitin and hyaluronic acid in the form of capsules for maintaining connective tissues, namely, joints and skin; Natural products for human use, namely, gel in the form of ampoules to combat fatigueSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 3, 2026C8..CANCELLED SEC. 8 (6-YR)—
Dec 17, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 17, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 14, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 13, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 12, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 12, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Nov 12, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 29, 2019IUAFUSE AMENDMENT FILED—
Oct 29, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Oct 29, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Oct 29, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 27, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 25, 2019EX1GSOU EXTENSION 1 GRANTED—
Sep 25, 2019EXT1SOU EXTENSION 1 FILED—
Sep 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 29, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 29, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 9, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 19, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 19, 2018ALIEASSIGNED TO LIE—
Dec 14, 2018ALIEASSIGNED TO LIE—
Dec 10, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 30, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2018DOCKASSIGNED TO EXAMINER—
Jul 23, 2018TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jul 23, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance